Vivani Medical
VANI
62 hedge funds and large institutions have $19.8M invested in Vivani Medical in 2015 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 20 increasing their positions, 10 reducing their positions, and 5 closing their positions.
240% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 5
100% more repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 10
91% more call options, than puts
Call options by funds: $1.91M | Put options by funds: $997K
50% more capital invested
Capital invested by funds: $13.2M → $19.8M (+$6.59M)
22% more funds holding
Funds holding: 51 → 62 (+11)
Top Buyers
Top Sellers
| 1 |
BL
Bolton LP
Greenwich,
Connecticut
|
-$494K |
| 2 |
Goldman Sachs
New York
|
-$340K |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$101K |
| 4 |
HCS
Harvest Capital Strategies
San Francisco,
California
|
-$94.6K |
| 5 |
Jane Street
New York
|
-$90K |
VANI Hedge Fund Activity: Q4 2015 in Review
62 of the 3,811 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q4 2015, worth a combined $19.8M — up 50% from $13.2M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new VANI positions and 5 closed out — a net gain of 12 holders — while 20 added to existing stakes and 10 trimmed.
The largest buyer was Zeke Capital Advisors, opening a new position worth an estimated $3.03M. The largest seller was Bolton LP, cutting an estimated $494K.
- 62 institutional investors held Vivani Medical (VANI) as of Q4 2015, up from 51 in Q3 2015.
- Funds reported $19.8M of Vivani Medical stock for Q4 2015, up 50% quarter-over-quarter.
- 17 funds opened new Vivani Medical positions in Q4 2015 and 5 closed out, a net change of +12 holders.
- The largest Vivani Medical buyer in Q4 2015 was Zeke Capital Advisors, an estimated $3.03M added.
- The largest Vivani Medical seller in Q4 2015 was Bolton LP, an estimated $494K sold.
Based on aggregated 13F filings for Q4 2015.